These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 9453491)
21. Insulin resistance-associated hepatic iron overload. Mendler MH; Turlin B; Moirand R; Jouanolle AM; Sapey T; Guyader D; Le Gall JY; Brissot P; David V; Deugnier Y Gastroenterology; 1999 Nov; 117(5):1155-63. PubMed ID: 10535879 [TBL] [Abstract][Full Text] [Related]
22. Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C. Lin TJ; Liao LY; Lin SY; Lin CL; Chang TA World J Gastroenterol; 2006 Aug; 12(30):4897-901. PubMed ID: 16937477 [TBL] [Abstract][Full Text] [Related]
23. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis. Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917 [TBL] [Abstract][Full Text] [Related]
24. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis. Deguti MM; Sipahi AM; Gayotto LC; Palácios SA; Bittencourt PL; Goldberg AC; Laudanna AA; Carrilho FJ; Cançado EL Braz J Med Biol Res; 2003 Jun; 36(6):739-45. PubMed ID: 12792703 [TBL] [Abstract][Full Text] [Related]
25. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344 [TBL] [Abstract][Full Text] [Related]
26. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507 [TBL] [Abstract][Full Text] [Related]
27. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. Ramm GA; Crawford DH; Powell LW; Walker NI; Fletcher LM; Halliday JW J Hepatol; 1997 Mar; 26(3):584-92. PubMed ID: 9075666 [TBL] [Abstract][Full Text] [Related]
28. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869 [TBL] [Abstract][Full Text] [Related]
29. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing. Nash S; Marconi S; Sikorska K; Naeem R; Nash G Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859 [TBL] [Abstract][Full Text] [Related]
30. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Bassett ML; Halliday JW; Powell LW Hepatology; 1986; 6(1):24-9. PubMed ID: 3943787 [TBL] [Abstract][Full Text] [Related]
31. A population-based study of the clinical expression of the hemochromatosis gene. Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457 [TBL] [Abstract][Full Text] [Related]
32. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249 [TBL] [Abstract][Full Text] [Related]
33. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Adams PC; Chakrabarti S Gastroenterology; 1998 Feb; 114(2):319-23. PubMed ID: 9453492 [TBL] [Abstract][Full Text] [Related]
34. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814 [TBL] [Abstract][Full Text] [Related]
35. Hemochromatosis gene HFE Cys282Tyr mutation analysis in a cohort of Northeast German hospitalized patients supports assumption of a North to South allele frequency gradient throughout Germany. Meier P; Schuff-Werner P; Steiner M Clin Lab; 2005; 51(9-10):539-43. PubMed ID: 16285477 [TBL] [Abstract][Full Text] [Related]
36. HFE genotype in patients with hemochromatosis and other liver diseases. Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365 [TBL] [Abstract][Full Text] [Related]
37. Phenotypic expression of a novel C282Y/R226G compound heterozygous state in HFE hemochromatosis: molecular dynamics and biochemical studies. Cézard C; Rabbind Singh A; Le Gac G; Gourlaouen I; Ferec C; Rochette J Blood Cells Mol Dis; 2014 Jan; 52(1):27-34. PubMed ID: 23953397 [TBL] [Abstract][Full Text] [Related]
38. Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. MacDonald GA; Bridle KR; Ward PJ; Walker NI; Houglum K; George DK; Smith JL; Powell LW; Crawford DH; Ramm GA J Gastroenterol Hepatol; 2001 Jun; 16(6):599-606. PubMed ID: 11422610 [TBL] [Abstract][Full Text] [Related]